• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
    • Dr. Prescott’s Columns
  • Patients
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for chemo

chemo

New use for OMRF brain cancer treatment could extend lives

December 18, 2019

In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.

Filed Under: News, Technology Ventures News Tagged With: battiste, brain cancer, cancer, center, chemo, drug, glioblastoma, James, Manu Nair, newsok, OKC, Oklahoma Medical Research Foundation, OKN-007, OMRF, ou, OUHSC, patient, Rheal, scientist-news, stephenson, technology ventures, temodar, therapy, Towner, treatment, university of oklahoma

Q BioMed Inc. finalizes license agreement with OMRF, RGCB

June 15, 2017

QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.

Filed Under: News, Technology Ventures News Tagged With: agreement, cancer, cells, chemo, denis corin, develop, drug, license, liver cancer, medical, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, otcqb, q biomed, qbio, rajiv gandhi centre for biotechnology, research, rgcb, Rheal, rheal towner, rights, scientist-news, therapy, Towner, uttrocide b

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In